Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar sami2009 (< 20) Submitted: 5/4/2010 8:24:27 PM : Outperform Start Price: $7.98 PCYC Score: +297.70

heavy accumulation

Report this Post Reply

Featured Broker Partners


Advertisement